\begin{table}[t!]
\centering
\resizebox{1.\linewidth}{!}{
\begin{tabular}{clcccc}
\toprule
\textbf{Attack} & \textbf{Defense} & \textbf{Llama$_\text{v3-8B}$} & \textbf{Qwen$_\text{v2-7B}$} & \textbf{Mistral$_\text{v0.3-7B}$} & \textbf{Vicuna$_\text{v1.5-7B}$} \\
\midrule
\multirow{4}{*}{\textbf{PAIR}}
& \texttt{R2D} & 1\% & 0\% & 11\% & 4\% \\
& \hspace{1em}w/o CPO & 1\%$_{(-)}$ & 8\%$_{\uparrow8}$ & 15\%$_{\uparrow4}$ & 27\%$_{\uparrow23}$ \\
& \hspace{1em}w/o Pivot & 0\%$_{\downarrow 1}$ & 10\%$_{\uparrow10}$ & 14\%$_{\uparrow3}$ & 31\%$_{\uparrow27}$ \\
& \cellcolor{gray!30}None & \cellcolor{gray!30}52\% & \cellcolor{gray!30}62\% & \cellcolor{gray!30}40\% & \cellcolor{gray!30}52\% \\
\midrule
\multirow{4}{*}{\textbf{GCG}} 
& \texttt{R2D} & 2\% & 0\% & 5\% & 0\% \\
& \hspace{1em}w/o CPO & 1\%$_{\downarrow1}$ & 12\%$_{\uparrow12}$ & 5\%$_{(-)}$ & 18\%$_{\uparrow18}$ \\
& \hspace{1em}w/o Pivot & 1\%$_{\downarrow1}$ & 20\%$_{\uparrow20}$ & 10\%$_{\uparrow5}$ & 20\%$_{\uparrow20}$ \\
& \cellcolor{gray!30}None & \cellcolor{gray!30}36\% & \cellcolor{gray!30}68\% & \cellcolor{gray!30}53\% & \cellcolor{gray!30}28\% \\
\midrule
\multirow{4}{*}{\textbf{JBC}} 
& \texttt{R2D} & 4\% & 0\% & 17\% & 37\% \\
& \hspace{1em}w/o CPO & 7\%$_{\uparrow3}$ & 4\%$_{\uparrow4}$ & 36\%$_{\uparrow19}$ & 49\%$_{\uparrow12}$ \\
& \hspace{1em}w/o Pivot & 12\%$_{\uparrow8}$ & 8\%$_{\uparrow8}$ & 52\%$_{\uparrow35}$ & 82\%$_{\uparrow45}$ \\ 
& \cellcolor{gray!30}None & \cellcolor{gray!30}46\% & \cellcolor{gray!30}92\% & \cellcolor{gray!30}66\% & \cellcolor{gray!30}92\% \\
\bottomrule
\end{tabular}
}
\caption{Ablation study results of \texttt{R2D} including the ASRs of the original LLMs alongside those of the \texttt{R2D}-enhanced models, as well as models used for ablation experiments with controlled variables. The symbols $\uparrow$ and $\downarrow$ indicate the changes in ASR relative to \texttt{R2D}.}
\label{tab:cpo_ablation}
\end{table} 